Europe Cartilage Degeneration Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others); and End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Country

No. of Pages: 110    |    Report Code: TIPRE00014168    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Cartilage Degeneration Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Cartilage Degeneration Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Cartilage Degeneration Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Aging population
  • 5.1.2 Rising incidence of osteoarthritis
5.2 Market Opportunities
  • 5.2.1 Increased investments in orthopedic research
  • 5.2.2 Growth in healthcare awareness
5.3 Future Trends
  • 5.3.1 Regenerative medicine advancements
  • 5.3.2 Use of 3D printing in treatment
5.4 Impact of Drivers and Restraints

6. Europe Cartilage Degeneration Market Regional Analysis

6.1 Europe Cartilage Degeneration Market Overview
6.2 Europe Cartilage Degeneration Market Revenue 2017-2027 (US$ Million)
6.3 Europe Cartilage Degeneration Market Forecast Analysis

7. Europe Cartilage Degeneration Market Analysis – by Procedure Type

7.1 Osteochondral Transplant
  • 7.1.1 Overview
  • 7.1.2 Osteochondral Transplant: Europe Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chondroplasty
  • 7.2.1 Overview
  • 7.2.2 Chondroplasty: Europe Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Joint Replacement
  • 7.3.1 Overview
  • 7.3.2 Joint Replacement: Europe Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Meniscus Transplants
  • 7.4.1 Overview
  • 7.4.2 Meniscus Transplants: Europe Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Cell-based Cartilage Resurfacing
  • 7.5.1 Overview
  • 7.5.2 Cell-based Cartilage Resurfacing: Europe Cartilage Degeneration Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Cartilage Degeneration Market Analysis – by Application

8.1 Knee
  • 8.1.1 Overview
  • 8.1.2 Knee: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Hips
  • 8.2.1 Overview
  • 8.2.2 Hips: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Cartilage Degeneration Market Analysis – by End User

9.1 Hospitals & Specialty Clinics
  • 9.1.1 Overview
  • 9.1.2 Hips: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Ambulatory Surgical Centers
  • 9.2.1 Overview
  • 9.2.2 Hips: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Academic & Research Institutes
  • 9.3.1 Overview
  • 9.3.2 Hips: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Cartilage Degeneration Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Cartilage Degeneration Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Europe Cartilage Degeneration Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 UK: Europe Cartilage Degeneration Market Breakdown, by Procedure Type
    • 10.1.1.1.2 UK: Europe Cartilage Degeneration Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Cartilage Degeneration Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Cartilage Degeneration Market Breakdown, by Procedure Type
    • 10.1.1.2.2 Germany: Europe Cartilage Degeneration Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Cartilage Degeneration Market Breakdown, by End User
  • 10.1.1.3 France: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 France: Europe Cartilage Degeneration Market Breakdown, by Procedure Type
    • 10.1.1.3.2 France: Europe Cartilage Degeneration Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Cartilage Degeneration Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Cartilage Degeneration Market Breakdown, by Procedure Type
    • 10.1.1.4.2 Russia: Europe Cartilage Degeneration Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Cartilage Degeneration Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Cartilage Degeneration Market Breakdown, by Procedure Type
    • 10.1.1.5.2 Italy: Europe Cartilage Degeneration Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Cartilage Degeneration Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Cartilage Degeneration Market Breakdown, by Procedure Type
    • 10.1.1.6.2 Rest of Europe: Europe Cartilage Degeneration Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Cartilage Degeneration Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Cartilage Degeneration Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 B. Braun Melsungen AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Smith & Nephew
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Stryker Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 CartiHeal, Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Vericel Corporation
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Cartilage Degeneration Market

The List of Companies - Europe Cartilage Degeneration Market

  1. B. Braun Melsungen AG
  2. Smith & Nephew
  3. Stryker Corporation
  4. CartiHeal, Inc
  5. Vericel Corporation

 

europe-cartilage-degeneration-market